American Chemical Society (ACS)
ACS Medicinal Chemistry Letters
,  volume 16 ,  issue 4 ,  pages 520-522

Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine

Publication type: Journal Article
Publication date: 2025-03-06
American Chemical Society (ACS)
scimago Q1
wos Q2
SJR: 0.805
CiteScore: 5.8
Impact factor: 4.0
ISSN: 19485875
Abstract
Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a new frontier in precision medicine. These innovations address critical challenges in neurological and psychiatric disorders, chronic pain management, and computational accessibility. By harnessing the principles of receptor modulation, targeted delivery systems, and simplified AI integration, these breakthroughs promise transformative solutions for patient care and technological development.
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Kargbo R. Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine // ACS Medicinal Chemistry Letters. 2025. Vol. 16. No. 4. pp. 520-522.
GOST all authors (up to 50) Copy
Kargbo R. Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine // ACS Medicinal Chemistry Letters. 2025. Vol. 16. No. 4. pp. 520-522.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acsmedchemlett.5c00112
UR - https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00112
TI - Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine
T2 - ACS Medicinal Chemistry Letters
AU - Kargbo, Robert
PY - 2025
DA - 2025/03/06
PB - American Chemical Society (ACS)
SP - 520-522
IS - 4
VL - 16
SN - 1948-5875
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Kargbo,
author = {Robert Kargbo},
title = {Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine},
journal = {ACS Medicinal Chemistry Letters},
year = {2025},
volume = {16},
publisher = {American Chemical Society (ACS)},
month = {mar},
url = {https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00112},
number = {4},
pages = {520--522},
doi = {10.1021/acsmedchemlett.5c00112}
}
MLA
Cite this
MLA Copy
Kargbo, Robert. “Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine.” ACS Medicinal Chemistry Letters, vol. 16, no. 4, Mar. 2025, pp. 520-522. https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00112.
Profiles